Study S000893

Investigation of Pharmacokinetics and Safety of HRS-7535 in Subjects With Mild and Moderate Hepatic Impairment and Normal Hepatic Function

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06961643
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 24
Start: 2025-06-05
Primary completion: 2026-01-22
Lead sponsor: Shandong Suncadia Medicine Co., Ltd.
Conditions: Diabetes Mellitus
Interventions: DRUG:HRS-7535 Tables
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

The maximum plasma concentration of HRS-7535 (Cmax) [Post-dose at day 1 to day 4.]
Area under the concentration curve from time 0 to the last quantifiable concentration (AUC0-t) [Post-dose at day 1 to day 4.]
Area under the concentration curve from time 0 to extrapolated infinite time (AUC0-inf) [Post-dose at day 1 to day 4.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.